VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
KNSL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
KNSLKinsale Capital Group, Inc.
$332.02$7.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksKNSLQuarterly Financials

Kinsale Capital Group, Inc. (KNSL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Kinsale Capital Group, Inc. (KNSL) quarterly income statement — complete revenue, gross profit & net income history

KNSL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue466.71M483.27M497.5M469.81M423.4M412.12M418.06M384.55M372.79M351.17M314.37M295.77M263.14M242.96M222.06M183.88M180.32M183.6M164.88M153.01M
Revenue Growth %10.23%17.26%19%22.17%13.57%17.36%32.98%30.02%41.67%44.54%41.57%60.85%45.93%32.33%34.68%20.17%30.4%31.77%34.6%29.99%
Medical Costs & Claims0213.2M272.44M257.09M268.66M228.05M233.98M226.73M218.32M189.01M185.19M174.09M165.64M137.87M159.03M130.15M124.63M108.14M106.77M79.11M
Medical Cost Ratio %0%44.12%54.76%54.72%63.45%55.33%55.97%58.96%58.56%53.82%58.91%58.86%62.95%56.74%71.61%70.78%69.12%58.9%64.75%51.71%
Gross Profit0270.07M225.07M212.73M154.74M184.08M184.08M157.82M154.47M162.16M129.18M121.67M97.5M105.1M63.03M53.73M55.69M75.46M58.12M73.89M
Gross Margin %0%55.88%45.24%45.28%36.55%44.67%44.03%41.04%41.44%46.18%41.09%41.14%37.05%43.26%28.39%29.22%30.88%41.1%35.25%48.29%
Gross Profit Growth %-100%46.71%22.27%34.79%0.18%13.51%42.5%29.71%58.43%54.29%104.93%126.48%75.08%39.28%8.46%-27.3%6.66%37.06%122.9%71.6%
Operating Expenses095.24M46.19M44.44M42.43M45.43M39.68M42.02M38.6M32.14M33.68M31.56M29.11M20.95M22.93M21.28M16.82M15.39M12.44M30.29M
OpEx / Revenue %0%19.71%9.28%9.46%10.02%11.02%9.49%10.93%10.35%9.15%10.71%10.67%11.06%8.62%10.33%11.57%9.33%8.38%7.54%19.79%
Depreciation & Amortization05.83M000000000000000000
Combined Ratio %0%63.82%64.04%64.18%73.47%66.36%65.46%69.89%68.92%62.98%69.62%69.53%74.01%65.37%81.94%82.36%78.44%67.28%72.3%71.5%
Operating Income0174.82M178.88M168.29M112.31M138.65M144.4M115.8M115.87M130.02M95.49M90.11M68.39M84.15M40.1M32.44M38.87M60.08M45.68M43.61M
Operating Margin %0%36.18%35.96%35.82%26.53%33.64%34.54%30.11%31.08%37.02%30.38%30.47%25.99%34.63%18.06%17.64%21.56%32.72%27.7%28.5%
Operating Income Growth %-100%26.09%23.88%45.33%-3.07%6.64%51.21%28.51%69.41%54.51%138.14%177.76%75.94%40.07%-12.21%-25.61%-1.44%40.3%183.35%19.66%
EBITDA0180.66M181.45M170.85M114.85M141.21M146.99M118.36M118.29M132.46M98.07M92.83M70.96M86.13M41.82M32.78M39.13M60.08M45.92M43.61M
EBITDA Margin %0%37.38%36.47%36.36%27.13%34.26%35.16%30.78%31.73%37.72%31.19%31.39%26.97%35.45%18.83%17.83%21.7%32.72%27.85%28.5%
Interest Expense3.17M2.98M2.57M2.56M2.54M2.56M2.59M2.56M2.42M2.43M2.57M2.72M2.57M1.98M1.72M337K253K0243K0
Non-Operating Income0-2.98M-2.57M-2.56M-2.54M-2.56M-2.59M-2.56M-2.42M-2.43M-2.57M-2.72M-2.57M-1.98M-1.72M-337K-253K0-243K0
Pretax Income139.66M174.82M178.88M168.29M112.31M138.65M144.4M115.8M115.87M130.02M95.49M90.11M68.39M84.15M40.1M32.44M38.87M60.08M45.68M43.61M
Pretax Margin %29.92%36.18%35.96%35.82%26.53%33.64%34.54%30.11%31.08%37.02%30.38%30.47%25.99%34.63%18.06%17.64%21.56%32.72%27.7%28.5%
Income Tax27.11M36.2M37.23M34.17M23.08M29.56M30.17M23.22M16.93M26.63M19.38M17.32M12.59M16.9M7.12M5.35M7.08M11.76M9.05M7.97M
Effective Tax Rate %19.41%20.71%20.81%20.3%20.55%21.32%20.89%20.05%14.61%20.48%20.29%19.22%18.41%20.08%17.75%16.5%18.22%19.57%19.82%18.28%
Net Income112.55M138.62M141.65M134.12M89.23M109.09M114.23M92.58M98.94M103.39M76.11M72.79M55.8M67.25M32.98M27.09M31.79M48.32M36.63M35.63M
Net Margin %24.12%28.68%28.47%28.55%21.07%26.47%27.32%24.07%26.54%29.44%24.21%24.61%21.21%27.68%14.85%14.73%17.63%26.32%22.21%23.29%
Net Income Growth %26.14%27.06%24%44.87%-9.82%5.52%50.07%27.18%77.31%53.74%130.76%168.7%75.52%39.17%-9.94%-23.98%-0.9%26.56%145.97%17.75%
EPS (Diluted)0.005.996.095.763.834.684.903.974.244.433.263.122.402.901.431.171.382.091.591.55
EPS Growth %-100%27.99%24.29%45.09%-9.67%5.64%50.31%27.24%76.67%52.76%127.97%166.67%73.91%38.76%-10.06%-24.52%-0.72%26.67%144.62%16.54%
EPS (Basic)0.006.016.125.793.854.714.934.004.284.483.303.162.432.941.451.191.402.131.611.57
Diluted Shares Outstanding023.16M23.27M23.29M23.33M23.33M23.34M23.33M23.34M23.32M23.32M23.3M23.29M23.21M23.11M23.1M23.09M23.08M23.06M23.05M